{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,8,17]],"date-time":"2026-08-17T18:11:45Z","timestamp":1786990305854,"version":"build-2736575974"},"reference-count":122,"publisher":"Elsevier BV","issue":"3","license":[{"start":{"date-parts":[[2025,9,1]],"date-time":"2025-09-01T00:00:00Z","timestamp":1756684800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2025,9,1]],"date-time":"2025-09-01T00:00:00Z","timestamp":1756684800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2025,9,1]],"date-time":"2025-09-01T00:00:00Z","timestamp":1756684800000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-017"},{"start":{"date-parts":[[2025,9,1]],"date-time":"2025-09-01T00:00:00Z","timestamp":1756684800000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-037"},{"start":{"date-parts":[[2025,9,1]],"date-time":"2025-09-01T00:00:00Z","timestamp":1756684800000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-012"},{"start":{"date-parts":[[2025,9,1]],"date-time":"2025-09-01T00:00:00Z","timestamp":1756684800000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-029"},{"start":{"date-parts":[[2025,9,1]],"date-time":"2025-09-01T00:00:00Z","timestamp":1756684800000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-004"}],"content-domain":{"domain":["clinicalkey.com","clinicalkey.com.au","clinicalkey.es","clinicalkey.fr","clinicalkey.jp","theclinics.com","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Infectious Disease Clinics of North America"],"published-print":{"date-parts":[[2025,9]]},"DOI":"10.1016\/j.idc.2025.02.009","type":"journal-article","created":{"date-parts":[[2025,4,11]],"date-time":"2025-04-11T07:22:53Z","timestamp":1744356173000},"page":"361-382","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":7,"title":["Optimizing Antibiotic Therapy in Musculoskeletal Infections"],"prefix":"10.1016","volume":"39","author":[{"given":"Nicol\u00e1s W.","family":"Cort\u00e9s-Penfield","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Julie Ann","family":"Justo","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Erin K.","family":"McCreary","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jonathan H.","family":"Ryder","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"issue":"5","key":"10.1016\/j.idc.2025.02.009_bib1","doi-asserted-by":"crossref","DOI":"10.1093\/ofid\/ofz181","article-title":"The history of antibiotic treatment of osteomyelitis","volume":"6","author":"Cort\u00e9s-Penfield","year":"2019","journal-title":"Open Forum Infect Dis"},{"issue":"1","key":"10.1016\/j.idc.2025.02.009_bib2","doi-asserted-by":"crossref","DOI":"10.1093\/ofid\/ofac706","article-title":"Can the future of ID escape the inertial dogma of its past? The exemplars of shorter is better and oral is the new IV","volume":"10","author":"Davar","year":"2023","journal-title":"Open Forum Infect Dis"},{"issue":"19","key":"10.1016\/j.idc.2025.02.009_bib3","doi-asserted-by":"crossref","first-page":"1537","DOI":"10.1001\/jama.279.19.1537","article-title":"Role of rifampin for treatment of orthopedic implant-related staphylococcal infections: a randomized controlled trial. Foreign-Body Infection (FBI) Study Group","volume":"279","author":"Zimmerli","year":"1998","journal-title":"JAMA"},{"key":"10.1016\/j.idc.2025.02.009_bib4","doi-asserted-by":"crossref","DOI":"10.1093\/cid\/ciad527","article-title":"IWGDF\/IDSA guidelines on the diagnosis and treatment of diabetes-related foot infections (IWGDF\/IDSA 2023)","author":"Senneville","year":"2023","journal-title":"Clin Infect Dis"},{"issue":"8","key":"10.1016\/j.idc.2025.02.009_bib5","doi-asserted-by":"crossref","first-page":"801","DOI":"10.1093\/jpids\/piab027","article-title":"Clinical practice guideline by the pediatric infectious diseases society and the infectious diseases society of America: 2021 guideline on diagnosis and management of acute hematogenous osteomyelitis in pediatrics","volume":"10","author":"Woods","year":"2021","journal-title":"J Pediatric Infect Dis Soc"},{"issue":"5","key":"10.1016\/j.idc.2025.02.009_bib6","doi-asserted-by":"crossref","DOI":"10.1001\/jamanetworkopen.2022.11321","article-title":"Use of novel strategies to develop guidelines for management of pyogenic osteomyelitis in adults: a WikiGuidelines group consensus statement","volume":"5","author":"Spellberg","year":"2022","journal-title":"JAMA Netw Open"},{"issue":"6","key":"10.1016\/j.idc.2025.02.009_bib7","doi-asserted-by":"crossref","first-page":"e26","DOI":"10.1093\/cid\/civ482","article-title":"2015 infectious diseases society of America (IDSA) clinical practice guidelines for the diagnosis and treatment of native vertebral osteomyelitis in adults","volume":"61","author":"Berbari","year":"2015","journal-title":"Clin Infect Dis"},{"issue":"1","key":"10.1016\/j.idc.2025.02.009_bib8","doi-asserted-by":"crossref","first-page":"e1","DOI":"10.1093\/cid\/cis803","article-title":"Diagnosis and management of prosthetic joint infection: clinical practice guidelines by the Infectious Diseases Society of America","volume":"56","author":"Osmon","year":"2013","journal-title":"Clin Infect Dis"},{"issue":"3","key":"10.1016\/j.idc.2025.02.009_bib9","doi-asserted-by":"crossref","first-page":"272","DOI":"10.1016\/j.ijantimicag.2012.10.023","article-title":"Current management of prosthetic joint infections in adults: results of an Emerging Infections Network survey","volume":"41","author":"Marschall","year":"2013","journal-title":"Int J Antimicrob Agents"},{"issue":"6","key":"10.1016\/j.idc.2025.02.009_bib10","doi-asserted-by":"crossref","DOI":"10.1093\/ofid\/ofae280","article-title":"Variation in North American infectious Disease specialists' practice regarding oral and suppressive antibiotics for adult osteoarticular infections: results of an emerging infections network (EIN) survey","volume":"11","author":"Cort\u00e9s-Penfield","year":"2024","journal-title":"Open Forum Infect Dis"},{"issue":"4","key":"10.1016\/j.idc.2025.02.009_bib11","doi-asserted-by":"crossref","first-page":"198","DOI":"10.1056\/NEJM197001222820406","article-title":"Osteomyelitis: a review of clinical features, therapeutic considerations and unusual aspects","volume":"282","author":"Waldvogel","year":"1970","journal-title":"N Engl J Med"},{"issue":"5","key":"10.1016\/j.idc.2025.02.009_bib12","doi-asserted-by":"crossref","first-page":"425","DOI":"10.1056\/NEJMoa1710926","article-title":"Oral versus intravenous antibiotics for bone and joint infection","volume":"380","author":"Li","year":"2019","journal-title":"N Engl J Med"},{"issue":"9","key":"10.1016\/j.idc.2025.02.009_bib13","doi-asserted-by":"crossref","first-page":"814","DOI":"10.1097\/INF.0000000000002790","article-title":"Daptomycin for pediatric gram-positive acute hematogenous osteomyelitis","volume":"39","author":"Bradley","year":"2020","journal-title":"Pediatr Infect Dis J"},{"issue":"7","key":"10.1016\/j.idc.2025.02.009_bib14","doi-asserted-by":"crossref","first-page":"e1539","DOI":"10.1093\/cid\/ciaa1758","article-title":"Three weeks versus six weeks of antibiotic therapy for diabetic foot osteomyelitis: a prospective, randomized, noninferiority pilot trial","volume":"73","author":"Gariani","year":"2021","journal-title":"Clin Infect Dis"},{"issue":"21","key":"10.1016\/j.idc.2025.02.009_bib15","doi-asserted-by":"crossref","first-page":"1991","DOI":"10.1056\/NEJMoa2020198","article-title":"Antibiotic therapy for 6 or 12 Weeks for prosthetic joint infection","volume":"384","author":"Bernard","year":"2021","journal-title":"N Engl J Med"},{"issue":"8","key":"10.1016\/j.idc.2025.02.009_bib16","doi-asserted-by":"crossref","first-page":"1114","DOI":"10.1136\/annrheumdis-2019-215116","article-title":"Two weeks versus four weeks of antibiotic therapy after surgical drainage for native joint bacterial arthritis: a prospective, randomised, non-inferiority trial","volume":"78","author":"Gjika","year":"2019","journal-title":"Ann Rheum Dis"},{"issue":"3","key":"10.1016\/j.idc.2025.02.009_bib17","doi-asserted-by":"crossref","first-page":"310","DOI":"10.1016\/j.ijantimicag.2016.05.021","article-title":"Short- versus long-duration levofloxacin plus rifampicin for acute staphylococcal prosthetic joint infection managed with implant retention: a randomised clinical trial","volume":"48","author":"Lora-Tamayo","year":"2016","journal-title":"Int J Antimicrob Agents"},{"issue":"9971","key":"10.1016\/j.idc.2025.02.009_bib18","doi-asserted-by":"crossref","first-page":"875","DOI":"10.1016\/S0140-6736(14)61233-2","article-title":"Antibiotic treatment for 6 weeks versus 12 weeks in patients with pyogenic vertebral osteomyelitis: an open-label, non-inferiority, randomised, controlled trial","volume":"385","author":"Bernard","year":"2015","journal-title":"Lancet"},{"issue":"2","key":"10.1016\/j.idc.2025.02.009_bib19","doi-asserted-by":"crossref","first-page":"302","DOI":"10.2337\/dc14-1514","article-title":"Six-week versus twelve-week antibiotic therapy for nonsurgically treated diabetic foot osteomyelitis: a multicenter open-label controlled randomized study","volume":"38","author":"Tone","year":"2015","journal-title":"Diabetes Care"},{"issue":"9","key":"10.1016\/j.idc.2025.02.009_bib20","doi-asserted-by":"crossref","first-page":"625","DOI":"10.1016\/S2352-4642(24)00133-0","article-title":"Oral versus intravenous empirical antibiotics in children and adolescents with uncomplicated bone and joint infections: a nationwide, randomised, controlled, non-inferiority trial in Denmark","volume":"8","author":"Nielsen","year":"2024","journal-title":"Lancet Child Adolesc Health"},{"issue":"1","key":"10.1016\/j.idc.2025.02.009_bib21","doi-asserted-by":"crossref","DOI":"10.1016\/j.ijantimicag.2022.106598","article-title":"Short- versus standard-course intravenous antibiotics for peri-prosthetic joint infections managed with debridement and implant retention: a randomised pilot trial using a desirability of outcome ranking (DOOR) endpoint","volume":"60","author":"Manning","year":"2022","journal-title":"Int J Antimicrob Agents"},{"issue":"3","key":"10.1016\/j.idc.2025.02.009_bib22","doi-asserted-by":"crossref","first-page":"317","DOI":"10.1097\/01241398-200205000-00009","article-title":"Short-term intravenous antibiotic treatment of acute hematogenous bone and joint infection in children: a prospective randomized trial","volume":"22","author":"Jaberi","year":"2002","journal-title":"J Pediatr Orthop"},{"issue":"6","key":"10.1016\/j.idc.2025.02.009_bib23","doi-asserted-by":"crossref","first-page":"2672","DOI":"10.1128\/AAC.01504-08","article-title":"Long-term follow-up trial of oral rifampin-cotrimoxazole combination versus intravenous cloxacillin in treatment of chronic staphylococcal osteomyelitis","volume":"53","author":"Euba","year":"2009","journal-title":"Antimicrob Agents Chemother"},{"issue":"9","key":"10.1016\/j.idc.2025.02.009_bib24","doi-asserted-by":"crossref","first-page":"1201","DOI":"10.1086\/597582","article-title":"Prospective, randomized trial of 10 days versus 30 days of antimicrobial treatment, including a short-term course of parenteral therapy, for childhood septic arthritis","volume":"48","author":"Peltola","year":"2009","journal-title":"Clin Infect Dis"},{"issue":"12","key":"10.1016\/j.idc.2025.02.009_bib25","doi-asserted-by":"crossref","first-page":"1123","DOI":"10.1097\/INF.0b013e3181f55a89","article-title":"Short- versus long-term antimicrobial treatment for acute hematogenous osteomyelitis of childhood: prospective, randomized trial on 131 culture-positive cases","volume":"29","author":"Peltola","year":"2010","journal-title":"Pediatr Infect Dis J"},{"issue":"11","key":"10.1016\/j.idc.2025.02.009_bib26","doi-asserted-by":"crossref","first-page":"5626","DOI":"10.1128\/AAC.00038-12","article-title":"Randomized controlled trial of the safety and efficacy of Daptomycin versus standard-of-care therapy for management of patients with osteomyelitis associated with prosthetic devices undergoing two-stage revision arthroplasty","volume":"56","author":"Byren","year":"2012","journal-title":"Antimicrob Agents Chemother"},{"issue":"4","key":"10.1016\/j.idc.2025.02.009_bib27","doi-asserted-by":"crossref","first-page":"469","DOI":"10.1016\/j.diagmicrobio.2013.12.007","article-title":"Phase 3 study comparing tigecycline and ertapenem in patients with diabetic foot infections with and without osteomyelitis","volume":"78","author":"Lauf","year":"2014","journal-title":"Diagn Microbiol Infect Dis"},{"issue":"9","key":"10.1016\/j.idc.2025.02.009_bib28","doi-asserted-by":"crossref","first-page":"1133","DOI":"10.1016\/j.cmi.2023.05.008","article-title":"Early switch from intravenous to oral antibiotic treatment in bone and joint infections","volume":"29","author":"Sendi","year":"2023","journal-title":"Clin Microbiol Infect"},{"issue":"5","key":"10.1016\/j.idc.2025.02.009_bib29","doi-asserted-by":"crossref","first-page":"1481","DOI":"10.1093\/jac\/dkac047","article-title":"Outpatient parenteral antimicrobial therapy (OPAT) in the UK: findings from the BSAC National Outcomes Registry (2015-19)","volume":"77","author":"Gilchrist","year":"2022","journal-title":"J Antimicrob Chemother"},{"issue":"4","key":"10.1016\/j.idc.2025.02.009_bib30","doi-asserted-by":"crossref","first-page":"420","DOI":"10.1017\/ice.2015.317","article-title":"Peripherally inserted central venous catheter complications in children receiving outpatient parenteral antibiotic therapy (OPAT)","volume":"37","author":"Kovacich","year":"2016","journal-title":"Infect Control Hosp Epidemiol"},{"issue":"4","key":"10.1016\/j.idc.2025.02.009_bib31","doi-asserted-by":"crossref","first-page":"476","DOI":"10.1002\/phar.2099","article-title":"Antimicrobial agents and catheter complications in outpatient parenteral antimicrobial therapy","volume":"38","author":"Keller","year":"2018","journal-title":"Pharmacotherapy"},{"issue":"3","key":"10.1016\/j.idc.2025.02.009_bib32","doi-asserted-by":"crossref","first-page":"357","DOI":"10.1007\/s15010-020-01398-4","article-title":"Efficacy and safety of a Belgian tertiary care outpatient parenteral antimicrobial therapy (OPAT) program","volume":"48","author":"Quintens","year":"2020","journal-title":"Infection"},{"issue":"9","key":"10.1016\/j.idc.2025.02.009_bib33","doi-asserted-by":"crossref","first-page":"e2582","DOI":"10.1093\/cid\/ciaa985","article-title":"Clinical experience of implementing oral versus intravenous antibiotics (OVIVA) in a specialist orthopedic hospital","volume":"73","author":"Azamgarhi","year":"2021","journal-title":"Clin Infect Dis"},{"issue":"12","key":"10.1016\/j.idc.2025.02.009_bib34","doi-asserted-by":"crossref","first-page":"1277","DOI":"10.1002\/phar.2872","article-title":"Switching from intravenous vancomycin to oral antibiotics reduces adverse events in a retrospective cohort of outpatients with orthopedic infections","volume":"43","author":"Gallagher","year":"2023","journal-title":"Pharmacotherapy"},{"issue":"4","key":"10.1016\/j.idc.2025.02.009_bib35","doi-asserted-by":"crossref","first-page":"234","DOI":"10.1542\/hpeds.2018-0193","article-title":"Economic burden of home antimicrobial therapy: OPAT versus oral therapy","volume":"9","author":"Krah","year":"2019","journal-title":"Hosp Pediatr"},{"issue":"9","key":"10.1016\/j.idc.2025.02.009_bib36","doi-asserted-by":"crossref","first-page":"1130","DOI":"10.1016\/j.ajic.2019.05.031","article-title":"What do patients say about their experience with urinary catheters and peripherally inserted central catheters?","volume":"47","author":"Trautner","year":"2019","journal-title":"Am J Infect Control"},{"issue":"2","key":"10.1016\/j.idc.2025.02.009_bib37","doi-asserted-by":"crossref","first-page":"156","DOI":"10.1177\/10600280221101105","article-title":"Evaluation of opportunities for oral antibiotic therapy in bone and joint infections","volume":"57","author":"Bhagat","year":"2023","journal-title":"Ann Pharmacother"},{"key":"10.1016\/j.idc.2025.02.009_bib38","doi-asserted-by":"crossref","first-page":"108","DOI":"10.12688\/wellcomeopenres.15314.3","article-title":"Cost-effectiveness of oral versus intravenous antibiotics (OVIVA) in patients with bone and joint infection: evidence from a non-inferiority trial","volume":"4","author":"McMeekin","year":"2019","journal-title":"Wellcome Open Res"},{"issue":"10","key":"10.1016\/j.idc.2025.02.009_bib39","doi-asserted-by":"crossref","first-page":"2603","DOI":"10.1093\/jac\/dkad239","article-title":"IV to oral switch: a novel viewpoint","volume":"78","author":"Jenkins","year":"2023","journal-title":"J Antimicrob Chemother"},{"issue":"11","key":"10.1016\/j.idc.2025.02.009_bib40","article-title":"Staphylococcus epidermidis biofilms have a high tolerance to antibiotics in periprosthetic joint infection","volume":"10","author":"Koch","year":"2020","journal-title":"Life (Basel)"},{"issue":"11","key":"10.1016\/j.idc.2025.02.009_bib41","doi-asserted-by":"crossref","first-page":"O911","DOI":"10.1111\/1469-0691.12649","article-title":"Gram-negative prosthetic joint infection: outcome of a debridement, antibiotics and implant retention approach. A large multicentre study","volume":"20","author":"Rodr\u00edguez-Pardo","year":"2014","journal-title":"Clin Microbiol Infect"},{"issue":"3","key":"10.1016\/j.idc.2025.02.009_bib42","first-page":"129","article-title":"Risk factors for failure in early prosthetic joint infection treated with debridement. Influence of etiology and antibiotic treatment","volume":"12","author":"Tornero","year":"2014","journal-title":"J Appl Biomater Funct Mater"},{"issue":"11","key":"10.1016\/j.idc.2025.02.009_bib43","doi-asserted-by":"crossref","first-page":"4772","DOI":"10.1128\/AAC.00188-09","article-title":"Outcome of acute prosthetic joint infections due to gram-negative bacilli treated with open debridement and retention of the prosthesis","volume":"53","author":"Mart\u00ednez-Pastor","year":"2009","journal-title":"Antimicrob Agents Chemother"},{"issue":"8","key":"10.1016\/j.idc.2025.02.009_bib44","doi-asserted-by":"crossref","first-page":"961","DOI":"10.1007\/s10096-010-0952-9","article-title":"Efficacy and safety of rifampin containing regimen for staphylococcal prosthetic joint infections treated with debridement and retention","volume":"29","author":"El Helou","year":"2010","journal-title":"Eur J Clin Microbiol Infect Dis"},{"issue":"9","key":"10.1016\/j.idc.2025.02.009_bib45","doi-asserted-by":"crossref","DOI":"10.1093\/ofid\/ofac363","article-title":"Truth in DAIR: duration of therapy and the use of quinolone\/rifampin-based regimens after debridement and implant retention for periprosthetic joint infections","volume":"9","author":"Tai","year":"2022","journal-title":"Open Forum Infect Dis"},{"issue":"12","key":"10.1016\/j.idc.2025.02.009_bib46","doi-asserted-by":"crossref","DOI":"10.1093\/ofid\/ofac582","article-title":"Adjunctive rifampin following debridement and implant retention for staphylococcal prosthetic joint infection: is it effective if not combined with a fluoroquinolone?","volume":"9","author":"Cort\u00e9s-Penfield","year":"2022","journal-title":"Open Forum Infect Dis"},{"issue":"5","key":"10.1016\/j.idc.2025.02.009_bib47","doi-asserted-by":"crossref","first-page":"191","DOI":"10.5194\/jbji-7-191-2022","article-title":"Intravenous antibiotic duration in the treatment of prosthetic joint infection: systematic review and meta-analysis","volume":"7","author":"Bouji","year":"2022","journal-title":"J Bone Jt Infect"},{"issue":"11","key":"10.1016\/j.idc.2025.02.009_bib48","doi-asserted-by":"crossref","first-page":"2790","DOI":"10.1111\/ans.18052","article-title":"Clinician-driven research priorities in bone and joint infection: perspectives of orthopaedic surgeons and infectious diseases physicians","volume":"92","author":"Davis","year":"2022","journal-title":"ANZ J Surg"},{"issue":"11","key":"10.1016\/j.idc.2025.02.009_bib49","doi-asserted-by":"crossref","DOI":"10.1001\/jamanetworkopen.2019.16003","article-title":"Adjunctive rifampin therapy for diabetic foot osteomyelitis in the veterans health administration","volume":"2","author":"Wilson","year":"2019","journal-title":"JAMA Netw Open"},{"issue":"1","key":"10.1016\/j.idc.2025.02.009_bib50","doi-asserted-by":"crossref","first-page":"23","DOI":"10.1186\/s12879-019-4751-3","article-title":"A multicenter randomized placebo controlled trial of rifampin to reduce pedal amputations for osteomyelitis in veterans with diabetes (VA INTREPID)","volume":"20","author":"Bessesen","year":"2020","journal-title":"BMC Infect Dis"},{"issue":"1","key":"10.1016\/j.idc.2025.02.009_bib51","doi-asserted-by":"crossref","first-page":"17","DOI":"10.1086\/380449","article-title":"Treating foot infections in diabetic patients: a randomized, multicenter, open-label trial of linezolid versus ampicillin-sulbactam\/amoxicillin-clavulanate","volume":"38","author":"Lipsky","year":"2004","journal-title":"Clin Infect Dis"},{"issue":"12","key":"10.1016\/j.idc.2025.02.009_bib52","doi-asserted-by":"crossref","first-page":"1163","DOI":"10.1111\/j.1469-0691.2009.02761.x","article-title":"Efficacy and tolerance of rifampicin-linezolid compared with rifampicin-cotrimoxazole combinations in prolonged oral therapy for bone and joint infections","volume":"15","author":"Nguyen","year":"2009","journal-title":"Clin Microbiol Infect"},{"issue":"6","key":"10.1016\/j.idc.2025.02.009_bib53","doi-asserted-by":"crossref","first-page":"582","DOI":"10.1111\/j.1469-0691.2011.03643.x","article-title":"Clindamycin vs. first-generation cephalosporins for acute osteoarticular infections of childhood--a prospective quasi-randomized controlled trial","volume":"18","author":"Peltola","year":"2012","journal-title":"Clin Microbiol Infect"},{"issue":"11\u201312","key":"10.1016\/j.idc.2025.02.009_bib54","doi-asserted-by":"crossref","first-page":"962","DOI":"10.3109\/00365548.2011.608082","article-title":"Efficacy of a combined oral clindamycin?rifampicin regimen for therapy of staphylococcal osteoarticular infections","volume":"43","author":"Czekaj","year":"2011","journal-title":"Scand J Infect Dis"},{"issue":"4","key":"10.1016\/j.idc.2025.02.009_bib55","doi-asserted-by":"crossref","first-page":"473","DOI":"10.1007\/s15010-015-0773-y","article-title":"Pharmacokinetic variability of clindamycin and influence of rifampicin on clindamycin concentration in patients with bone and joint infections","volume":"43","author":"Curis","year":"2015","journal-title":"Infection"},{"issue":"1","key":"10.1016\/j.idc.2025.02.009_bib56","doi-asserted-by":"crossref","first-page":"321","DOI":"10.1186\/s12879-017-2429-2","article-title":"Clindamycin-rifampin combination therapy for staphylococcal periprosthetic joint infections: a retrospective observational study","volume":"17","author":"Leijtens","year":"2017","journal-title":"BMC Infect Dis"},{"issue":"9","key":"10.1016\/j.idc.2025.02.009_bib57","doi-asserted-by":"crossref","first-page":"1634","DOI":"10.1093\/cid\/ciab426","article-title":"If, when, and how to use rifampin in acute staphylococcal periprosthetic joint infections, a multicentre observational study","volume":"73","author":"Beldman","year":"2021","journal-title":"Clin Infect Dis"},{"issue":"Suppl B","key":"10.1016\/j.idc.2025.02.009_bib58","doi-asserted-by":"crossref","first-page":"149","DOI":"10.1093\/jac\/10.suppl_B.149","article-title":"Oral cefadroxil in the treatment of bone and joint infections in children and adults","volume":"10","author":"Jimenez-Shehab","year":"1982","journal-title":"J Antimicrob Chemother"},{"issue":"Suppl 1","key":"10.1016\/j.idc.2025.02.009_bib59","first-page":"106","article-title":"Cefadroxil in the treatment of osteomyelitis in children","volume":"8","author":"Schwob","year":"1980","journal-title":"J Int Med Res"},{"issue":"12","key":"10.1016\/j.idc.2025.02.009_bib60","doi-asserted-by":"crossref","first-page":"590","DOI":"10.1093\/jpids\/piac104","article-title":"Cefadroxil use for musculoskeletal infections in an academic pediatric hospital","volume":"11","author":"Weslander","year":"2022","journal-title":"J Pediatric Infect Dis Soc"},{"issue":"6","key":"10.1016\/j.idc.2025.02.009_bib61","doi-asserted-by":"crossref","first-page":"523","DOI":"10.1097\/INF.0000000000002661","article-title":"Frequency of dosing of cephalexin for oral step-down therapy of pediatric osteoarticular infections caused by methicillin-sensitive Staphylococcus aureus","volume":"39","author":"Ramchandar","year":"2020","journal-title":"Pediatr Infect Dis J"},{"issue":"1","key":"10.1016\/j.idc.2025.02.009_bib62","doi-asserted-by":"crossref","first-page":"307","DOI":"10.1186\/s12879-023-08266-0","article-title":"Effectiveness of oral cephalexin in antibiotic-course completion for methicillin-susceptible Staphylococcus aureus-induced bacteremic vertebral osteomyelitis","volume":"23","author":"Okumura","year":"2023","journal-title":"BMC Infect Dis"},{"issue":"5","key":"10.1016\/j.idc.2025.02.009_bib63","article-title":"High efficacy of oral tetracyclines in prosthetic joint infection treated with debridement, antibiotics, and implant retention (DAIR) or resection arthroplasty with destination spacer placement","volume":"16","author":"Jang","year":"2024","journal-title":"Cureus"},{"issue":"3","key":"10.1016\/j.idc.2025.02.009_bib64","doi-asserted-by":"crossref","first-page":"110","DOI":"10.7150\/jbji.43254","article-title":"Minocycline combined with vancomycin for the treatment of methicillin-resistant coagulase-negative staphylococcal prosthetic joint infection managed with exchange arthroplasty","volume":"5","author":"Bart","year":"2020","journal-title":"J Bone Jt Infect"},{"issue":"8","key":"10.1016\/j.idc.2025.02.009_bib65","doi-asserted-by":"crossref","DOI":"10.1093\/ofid\/ofac366","article-title":"Oral versus standard antimicrobial treatment for pyogenic native vertebral osteomyelitis: a single-center, retrospective, propensity score-balanced analysis","volume":"9","author":"Marconi","year":"2022","journal-title":"Open Forum Infect Dis"},{"issue":"6","key":"10.1016\/j.idc.2025.02.009_bib66","doi-asserted-by":"crossref","first-page":"1483","DOI":"10.1111\/dom.13651","article-title":"Oral amoxicillin-clavulanate for treating diabetic foot infections","volume":"21","author":"Gariani","year":"2019","journal-title":"Diabetes Obes Metab"},{"issue":"2","key":"10.1016\/j.idc.2025.02.009_bib67","doi-asserted-by":"crossref","first-page":"235","DOI":"10.1093\/jac\/dkm476","article-title":"Tissue concentrations: do we ever learn?","volume":"61","author":"Mouton","year":"2008","journal-title":"J Antimicrob Chemother"},{"issue":"2","key":"10.1016\/j.idc.2025.02.009_bib68","doi-asserted-by":"crossref","first-page":"89","DOI":"10.2165\/00003088-200948020-00002","article-title":"Penetration of antibacterials into bone: pharmacokinetic, pharmacodynamic and bioanalytical considerations","volume":"48","author":"Landersdorfer","year":"2009","journal-title":"Clin Pharmacokinet"},{"issue":"3","key":"10.1016\/j.idc.2025.02.009_bib69","doi-asserted-by":"crossref","first-page":"259","DOI":"10.1016\/j.psym.2017.11.001","article-title":"Fluoroquinolone-related neuropsychiatric events in hospitalized veterans","volume":"59","author":"Sellick","year":"2018","journal-title":"Psychosomatics"},{"issue":"10","key":"10.1016\/j.idc.2025.02.009_bib70","first-page":"779","article-title":"The frequency of, and predisposing risk factors for, ciprofloxacin-induced neuro-psychiatric adverse drug reactions","volume":"124","author":"Hartinger","year":"2023","journal-title":"Bratisl Lek Listy"},{"key":"10.1016\/j.idc.2025.02.009_bib71","article-title":"European society of clinical microbiology and infectious diseases (ESCMID) global 2024","volume":"42","author":"Mar\u00edn-Hernandez","year":"2024","journal-title":"Lancet Reg Health Eur"},{"issue":"1","key":"10.1016\/j.idc.2025.02.009_bib72","doi-asserted-by":"crossref","DOI":"10.1093\/ofid\/ofy331","article-title":"Dalbavancin for the treatment of osteomyelitis in adult patients: a randomized clinical trial of efficacy and safety","volume":"6","author":"Rappo","year":"2019","journal-title":"Open Forum Infect Dis"},{"issue":"3","key":"10.1016\/j.idc.2025.02.009_bib73","doi-asserted-by":"crossref","first-page":"ofae070","DOI":"10.1093\/ofid\/ofae070","article-title":"Dalba got back? Use of dalbavancin for the treatment of vertebral osteomyelitis","volume":"11","author":"Streifel","year":"2024","journal-title":"Open Forum Infect Dis"},{"issue":"2","key":"10.1016\/j.idc.2025.02.009_bib74","doi-asserted-by":"crossref","first-page":"ofab589","DOI":"10.1093\/ofid\/ofab589","article-title":"Effectiveness of dalbavancin compared with standard of care for the treatment of osteomyelitis: a real-world analysis","volume":"9","author":"Cain","year":"2022","journal-title":"Open Forum Infect Dis"},{"issue":"3","key":"10.1016\/j.idc.2025.02.009_bib75","doi-asserted-by":"crossref","first-page":"535","DOI":"10.1007\/s40121-024-00925-2","article-title":"Oritavancin versus daptomycin for osteomyelitis treatment after surgical debridement","volume":"13","author":"Van Hise","year":"2024","journal-title":"Infect Dis Ther"},{"issue":"Suppl 1","key":"10.1016\/j.idc.2025.02.009_bib76","doi-asserted-by":"crossref","first-page":"46","DOI":"10.1007\/s40801-020-00194-8","article-title":"Real-world use of oritavancin for the treatment of osteomyelitis","volume":"7","author":"Scoble","year":"2020","journal-title":"Drugs Real World Outcomes"},{"issue":"Suppl 1","key":"10.1016\/j.idc.2025.02.009_bib77","doi-asserted-by":"crossref","first-page":"41","DOI":"10.1007\/s40801-020-00195-7","article-title":"Treatment of acute osteomyelitis with once-weekly oritavancin: a two-year, multicenter, retrospective study","volume":"7","author":"Van Hise","year":"2020","journal-title":"Drugs Real World Outcomes"},{"issue":"11","key":"10.1016\/j.idc.2025.02.009_bib78","doi-asserted-by":"crossref","first-page":"2809","DOI":"10.1007\/s00264-024-06295-1","article-title":"Bacteriophage therapy as an innovative strategy for the treatment of Periprosthetic Joint Infection: a systematic review","volume":"48","author":"Yang","year":"2024","journal-title":"Int Orthop"},{"issue":"3","key":"10.1016\/j.idc.2025.02.009_bib79","doi-asserted-by":"crossref","DOI":"10.1128\/spectrum.04918-22","article-title":"Optimization of phage-antibiotic combinations against Staphylococcus aureus biofilms","volume":"11","author":"Kebriaei","year":"2023","journal-title":"Microbiol Spectr"},{"issue":"8","key":"10.1016\/j.idc.2025.02.009_bib80","doi-asserted-by":"crossref","DOI":"10.1128\/aac.00655-24","article-title":"Phase 1 study of the pharmacokinetics and clinical proof-of-concept activity of a biofilm-disrupting human monoclonal antibody in patients with chronic prosthetic joint infection of the knee or hip","volume":"68","author":"Conway","year":"2024","journal-title":"Antimicrob Agents Chemother"},{"issue":"4","key":"10.1016\/j.idc.2025.02.009_bib81","doi-asserted-by":"crossref","first-page":"362","DOI":"10.18683\/germs.2023.1406","article-title":"Epidemiology of Pseudomonas aeruginosa in diabetic foot infections: a global systematic review and meta-analysis","volume":"13","author":"Garousi","year":"2023","journal-title":"Germs"},{"issue":"11","key":"10.1016\/j.idc.2025.02.009_bib82","doi-asserted-by":"crossref","DOI":"10.1093\/ofid\/ofae621","article-title":"Correlating climate conditions with Pseudomonas aeruginosa prevalence in diabetic foot infections within the United States","volume":"11","author":"Winski","year":"2024","journal-title":"Open Forum Infect Dis"},{"issue":"7","key":"10.1016\/j.idc.2025.02.009_bib83","doi-asserted-by":"crossref","DOI":"10.1093\/ofid\/ofac297","article-title":"Prevalence and predictors of Pseudomonas aeruginosa among hospitalized patients with diabetic foot infections","volume":"9","author":"Veve","year":"2022","journal-title":"Open Forum Infect Dis"},{"issue":"6","key":"10.1016\/j.idc.2025.02.009_bib84","doi-asserted-by":"crossref","DOI":"10.1093\/ofid\/ofae258","article-title":"Antipseudomonal antibiotics in diabetic foot infections: a practical perspective from a community hospital","volume":"11","author":"Lau","year":"2024","journal-title":"Open Forum Infect Dis"},{"issue":"9","key":"10.1016\/j.idc.2025.02.009_bib85","article-title":"Systemic antibiotics for treating diabetic foot infections","volume":"2015","author":"Selva","year":"2015","journal-title":"Cochrane Database Syst Rev"},{"issue":"1","key":"10.1016\/j.idc.2025.02.009_bib86","doi-asserted-by":"crossref","first-page":"e39","DOI":"10.1017\/ash.2023.123","article-title":"Impact of a syndrome-specific antibiotic stewardship intervention on antipseudomonal antibiotic use in inpatient diabetic foot infection management","volume":"3","author":"McCreery","year":"2023","journal-title":"Antimicrob Steward Healthc Epidemiol"},{"issue":"10","key":"10.1016\/j.idc.2025.02.009_bib87","doi-asserted-by":"crossref","DOI":"10.1001\/jamanetworkopen.2023.40457","article-title":"Incidence, microbiological studies, and factors associated with prosthetic joint infection after total knee arthroplasty","volume":"6","author":"Weinstein","year":"2023","journal-title":"JAMA Netw Open"},{"issue":"2","key":"10.1016\/j.idc.2025.02.009_bib88","doi-asserted-by":"crossref","first-page":"255","DOI":"10.1016\/j.cmi.2021.06.006","article-title":"Microbiology of hip and knee periprosthetic joint infections: a database study","volume":"28","author":"Tai","year":"2022","journal-title":"Clin Microbiol Infect"},{"issue":"5","key":"10.1016\/j.idc.2025.02.009_bib89","doi-asserted-by":"crossref","first-page":"880","DOI":"10.1016\/j.spinee.2018.11.012","article-title":"Comparison of pyogenic postoperative and native vertebral osteomyelitis","volume":"19","author":"Kim","year":"2019","journal-title":"Spine J"},{"issue":"5","key":"10.1016\/j.idc.2025.02.009_bib90","doi-asserted-by":"crossref","first-page":"1168","DOI":"10.1093\/jac\/dkr047","article-title":"Adult native septic arthritis: a review of 10 years of experience and lessons for empirical antibiotic therapy","volume":"66","author":"Clerc","year":"2011","journal-title":"J Antimicrob Chemother"},{"issue":"3","key":"10.1016\/j.idc.2025.02.009_bib91","doi-asserted-by":"crossref","DOI":"10.1093\/ofid\/ofaa089","article-title":"Septic arthritis and the opioid epidemic: 1465 cases of culture-positive native joint septic arthritis from 1990-2018","volume":"7","author":"Ross","year":"2020","journal-title":"Open Forum Infect Dis"},{"key":"10.1016\/j.idc.2025.02.009_bib92","doi-asserted-by":"crossref","DOI":"10.3389\/fcimb.2022.934485","article-title":"The microbiological etiology of fracture-related infection","volume":"12","author":"Depypere","year":"2022","journal-title":"Front Cell Infect Microbiol"},{"issue":"9","key":"10.1016\/j.idc.2025.02.009_bib93","article-title":"Microbiological profile of fracture related infection at a UK major trauma centre","volume":"12","author":"Patel","year":"2023","journal-title":"Antibiotics (Basel)"},{"issue":"10","key":"10.1016\/j.idc.2025.02.009_bib94","doi-asserted-by":"crossref","DOI":"10.1093\/ofid\/ofaa412","article-title":"Diabetic foot infections: local prevalence of and case-control study of risk factors for methicillin-resistant Staphylococcus aureus and Pseudomonas aeruginosa","volume":"7","author":"Kim","year":"2020","journal-title":"Open Forum Infect Dis"},{"issue":"10","key":"10.1016\/j.idc.2025.02.009_bib95","doi-asserted-by":"crossref","first-page":"1262","DOI":"10.1093\/cid\/ciw098","article-title":"Optimal duration of antibiotic therapy in patients with hematogenous vertebral osteomyelitis at low risk and high risk of recurrence","volume":"62","author":"Park","year":"2016","journal-title":"Clin Infect Dis"},{"issue":"2","key":"10.1016\/j.idc.2025.02.009_bib96","doi-asserted-by":"crossref","first-page":"338","DOI":"10.1093\/cid\/ciy559","article-title":"Osteomyelitis complicating sacral pressure ulcers: whether or not to treat with antibiotic therapy","volume":"68","author":"Wong","year":"2019","journal-title":"Clin Infect Dis"},{"issue":"2","key":"10.1016\/j.idc.2025.02.009_bib97","doi-asserted-by":"crossref","DOI":"10.1002\/edm2.59","article-title":"Stopping antibiotics after surgical amputation in diabetic foot and ankle infections-A daily practice cohort","volume":"2","author":"Rossel","year":"2019","journal-title":"Endocrinol Diabetes Metab"},{"issue":"1","key":"10.1016\/j.idc.2025.02.009_bib98","doi-asserted-by":"crossref","first-page":"188","DOI":"10.1093\/cid\/ciad484","article-title":"How we approach suppressive antibiotic therapy following debridement, antibiotics, and implant retention for prosthetic joint infection","volume":"78","author":"Cortes-Penfield","year":"2024","journal-title":"Clin Infect Dis"},{"issue":"5","key":"10.1016\/j.idc.2025.02.009_bib99","doi-asserted-by":"crossref","DOI":"10.1093\/ofid\/ofae216","article-title":"Role of routine suppressive antibiotic therapy after debridement, antibiotics, and implant retention for acute periprosthetic joint infections","volume":"11","author":"Tai","year":"2024","journal-title":"Open Forum Infect Dis"},{"issue":"6","key":"10.1016\/j.idc.2025.02.009_bib100","doi-asserted-by":"crossref","DOI":"10.1016\/j.jinf.2024.106316","article-title":"Global practice variation of suppressive antimicrobial treatment for prosthetic joint infections: a cross-sectional survey study","volume":"89","author":"Hanssen","year":"2024","journal-title":"J Infect"},{"issue":"3","key":"10.1016\/j.idc.2025.02.009_bib101","doi-asserted-by":"crossref","first-page":"143","DOI":"10.5194\/jbji-9-143-2024","article-title":"No differences in outcomes with stopping or continuing antibiotic suppression in periprosthetic joint infections","volume":"9","author":"Furukawa","year":"2024","journal-title":"J Bone Jt Infect"},{"issue":"4","key":"10.1016\/j.idc.2025.02.009_bib102","doi-asserted-by":"crossref","first-page":"559","DOI":"10.1093\/cid\/ciz261","article-title":"Benefits and adverse events associated with extended antibiotic use in total knee arthroplasty periprosthetic joint infection","volume":"70","author":"Shah","year":"2020","journal-title":"Clin Infect Dis"},{"issue":"20","key":"10.1016\/j.idc.2025.02.009_bib103","doi-asserted-by":"crossref","first-page":"2213","DOI":"10.1001\/jama.1979.03300200043023","article-title":"Hematogenous infection in total joint replacement. Recommendations for prophylactic antibiotics","volume":"242","author":"Lattimer","year":"1979","journal-title":"JAMA"},{"issue":"9s2","key":"10.1016\/j.idc.2025.02.009_bib104","doi-asserted-by":"crossref","first-page":"S420","DOI":"10.1016\/j.arth.2024.02.046","article-title":"Antibiotic prophylaxis prior to dental procedures after total hip and knee arthroplasty does not decrease the risk of periprosthetic joint infection","volume":"39","author":"Simon","year":"2024","journal-title":"J Arthroplast"},{"issue":"6","key":"10.1016\/j.idc.2025.02.009_bib105","doi-asserted-by":"crossref","first-page":"1091","DOI":"10.1016\/j.arth.2013.11.024","article-title":"Antibiotic prophylaxis for dental procedures at risk of causing bacteremia among post-total joint arthroplasty patients: a survey of Canadian orthopaedic surgeons and dental surgeons","volume":"29","author":"Colterjohn","year":"2014","journal-title":"J Arthroplast"},{"issue":"5","key":"10.1016\/j.idc.2025.02.009_bib106","doi-asserted-by":"crossref","DOI":"10.1001\/jamanetworkopen.2019.3909","article-title":"Assessment of the appropriateness of antibiotic prescriptions for infection prophylaxis before dental procedures, 2011 to 2015","volume":"2","author":"Suda","year":"2019","journal-title":"JAMA Netw Open"},{"issue":"3","key":"10.1016\/j.idc.2025.02.009_bib107","doi-asserted-by":"crossref","first-page":"180","DOI":"10.5435\/JAAOS-21-03-180","article-title":"Prevention of orthopaedic implant infection in patients undergoing dental procedures","volume":"21","author":"Watters","year":"2013","journal-title":"J Am Acad Orthop Surg"},{"issue":"1","key":"10.1016\/j.idc.2025.02.009_bib108","doi-asserted-by":"crossref","first-page":"11","DOI":"10.1016\/j.adaj.2014.11.012","article-title":"The use of prophylactic antibiotics prior to dental procedures in patients with prosthetic joints: evidence-based clinical practice guideline for dental practitioners--a report of the American Dental Association Council on Scientific Affairs","volume":"146","author":"Sollecito","year":"2015","journal-title":"J Am Dent Assoc"},{"issue":"4","key":"10.1016\/j.idc.2025.02.009_bib109","doi-asserted-by":"crossref","first-page":"1145","DOI":"10.1016\/j.jos.2023.07.017","article-title":"Association between dental procedures and periprosthetic joint infection: a case-crossover study","volume":"29","author":"Masuda","year":"2024","journal-title":"J Orthop Sci"},{"issue":"1","key":"10.1016\/j.idc.2025.02.009_bib110","doi-asserted-by":"crossref","first-page":"8","DOI":"10.1086\/648676","article-title":"Dental procedures as risk factors for prosthetic hip or knee infection: a hospital-based prospective case-control study","volume":"50","author":"Berbari","year":"2010","journal-title":"Clin Infect Dis"},{"issue":"1","key":"10.1016\/j.idc.2025.02.009_bib111","doi-asserted-by":"crossref","DOI":"10.1001\/jamanetworkopen.2021.42987","article-title":"Analysis of prosthetic joint infections following invasive dental procedures in England","volume":"5","author":"Thornhill","year":"2022","journal-title":"JAMA Netw Open"},{"issue":"2","key":"10.1016\/j.idc.2025.02.009_bib112","doi-asserted-by":"crossref","first-page":"154","DOI":"10.1017\/ice.2016.248","article-title":"Prosthetic joint infection following invasive dental procedures and antibiotic prophylaxis in patients with hip or knee arthroplasty","volume":"38","author":"Kao","year":"2017","journal-title":"Infect Control Hosp Epidemiol"},{"issue":"3","key":"10.1016\/j.idc.2025.02.009_bib113","doi-asserted-by":"crossref","first-page":"846","DOI":"10.1111\/odi.14531","article-title":"Bacteremia following different oral procedures: systematic review and meta-analysis","volume":"30","author":"Martins","year":"2024","journal-title":"Oral Dis"},{"key":"10.1016\/j.idc.2025.02.009_bib114","doi-asserted-by":"crossref","first-page":"82","DOI":"10.1016\/j.jor.2024.02.037","article-title":"Antibiotic prophylaxis prior to colonoscopy with biopsy does not decrease risk of prosthetic joint infection in total knee arthroplasty recipients","volume":"53","author":"Albana","year":"2024","journal-title":"J Orthop"},{"issue":"8","key":"10.1016\/j.idc.2025.02.009_bib115","doi-asserted-by":"crossref","first-page":"1591","DOI":"10.1016\/j.arth.2023.02.019","article-title":"Diagnostic and invasive colonoscopy are not risk factors for revision surgery due to periprosthetic joint infection","volume":"38","author":"Chiu","year":"2023","journal-title":"J Arthroplast"},{"issue":"12","key":"10.1016\/j.idc.2025.02.009_bib116","doi-asserted-by":"crossref","first-page":"5562","DOI":"10.1007\/s10620-022-07475-y","article-title":"Gastrointestinal endoscopy and the risk of prosthetic joint infection: a nationwide database analysis","volume":"67","author":"Wang","year":"2022","journal-title":"Dig Dis Sci"},{"issue":"7","key":"10.1016\/j.idc.2025.02.009_bib117","doi-asserted-by":"crossref","first-page":"1223","DOI":"10.1016\/j.arth.2022.02.014","article-title":"Antibiotic prophylaxis for prosthetic joint patients undergoing invasive dental procedures: time for a rethink?","volume":"37","author":"Springer","year":"2022","journal-title":"J Arthroplast"},{"issue":"8","key":"10.1016\/j.idc.2025.02.009_bib118","doi-asserted-by":"crossref","DOI":"10.1093\/ofid\/ofac361","article-title":"Private practice dentists improve antibiotic use after dental antibiotic stewardship education from infectious diseases experts","volume":"9","author":"Goff","year":"2022","journal-title":"Open Forum Infect Dis"},{"issue":"3","key":"10.1016\/j.idc.2025.02.009_bib119","doi-asserted-by":"crossref","DOI":"10.1093\/ofid\/ofz067","article-title":"Successful implementation of an antibiotic stewardship program in an academic dental practice","volume":"6","author":"Gross","year":"2019","journal-title":"Open Forum Infect Dis"},{"issue":"2","key":"10.1016\/j.idc.2025.02.009_bib120","doi-asserted-by":"crossref","first-page":"380","DOI":"10.1016\/j.japh.2023.11.010","article-title":"Impact of stewardship intervention on antibiotic prescribing prior to dental procedures in a veteran population","volume":"64","author":"Wojtowicz","year":"2024","journal-title":"J Am Pharm Assoc (2003)"},{"issue":"8","key":"10.1016\/j.idc.2025.02.009_bib121","doi-asserted-by":"crossref","first-page":"2394","DOI":"10.1093\/jac\/dkz202","article-title":"Four versus six weeks of antibiotic therapy for osteoarticular infections after implant removal: a randomized trial","volume":"74","author":"Benkabouche","year":"2019","journal-title":"J Antimicrob Chemother"},{"issue":"2","key":"10.1016\/j.idc.2025.02.009_bib122","doi-asserted-by":"crossref","first-page":"233","DOI":"10.1097\/SLA.0000000000005205","article-title":"Moderate to severe soft tissue diabetic foot infections: a randomized, controlled, pilot trial of post-debridement antibiotic treatment for 10 versus 20 days","volume":"276","author":"Pham","year":"2022","journal-title":"Ann Surg"}],"container-title":["Infectious Disease Clinics of North America"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0891552025000145?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0891552025000145?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2025,7,25]],"date-time":"2025-07-25T20:35:49Z","timestamp":1753475749000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0891552025000145"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2025,9]]},"references-count":122,"journal-issue":{"issue":"3","published-print":{"date-parts":[[2025,9]]}},"alternative-id":["S0891552025000145"],"URL":"https:\/\/doi.org\/10.1016\/j.idc.2025.02.009","relation":{},"ISSN":["0891-5520"],"issn-type":[{"value":"0891-5520","type":"print"}],"subject":[],"published":{"date-parts":[[2025,9]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Optimizing Antibiotic Therapy in Musculoskeletal Infections","name":"articletitle","label":"Article Title"},{"value":"Infectious Disease Clinics of North America","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.idc.2025.02.009","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2025 Elsevier Inc. All rights are reserved, including those for text and data mining, AI training, and similar technologies.","name":"copyright","label":"Copyright"}]}}